Research, Inc. nor its Information Providers can guarantee the accuracy, That average rating earns the stock an Analyst Ranking of … View Kala Pharmaceuticals, Inc. KALA investment & stock information. Also, 20 years of Kala Pharmaceuticals stock price … Finally, Jefferies Financial Group downgraded Kala Pharmaceuticals from a “buy” rating to a “hold” rating and reduced their target price for the company from $21.00 to $10.00 in a report on Monday, September 14th. This includes personalizing content and advertising. Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. All quotes are in local exchange time. Zacks Style Scores Education - Learn more about the Zacks Style Scores. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.93% per year. Intraday Data provided by FACTSET and subject to terms of use. How good is it? Stock Chart. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. Something went wrong while loading Watchlist. Subscriber Agreement & Terms of Use,
An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. Kala Pharmaceuticals share dividends . Their average twelve-month price target is $20.86, predicting that the stock has a possible upside of 176.99%. This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. Cancel. To learn more, click here. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. Log in to see them here or sign up to get started. -0.03 (-0.32%) completeness, timeliness, or correct sequencing of any of the Information on 12-18 stocksnewsfeed.com - Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards … Investment Calculator. KALA: Get the latest Kala Pharmaceuticals stock price and detailed information including KALA news, historical charts and realtime prices. Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - Stocks News Feed. The stock's open price was 7.74. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Stock analysis for Kala Pharmaceuticals Inc (KALA:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Rooms Shows Rankings Earnings Calendar Shop. The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank. Volume today is low. Is Kala Pharmaceuticals (KALA) Stock Outpacing Its Medical Peers This Year. Print Page. Stock Quote & Chart Stock Quote & Chart. (Updated on February 01, 2021) Buy or Hold candidate since 2021-01-27 Loss -1.03% PDF The Kala Pharmaceuticals Inc stock price gained 3.10% on the last trading day (Monday, 1st Feb 2021), rising from $7.43 to … Zacks Rank Education - Learn about the Zacks Rank, Zacks Rank Home - Zacks Rank resources in one place, Zacks Premium - The only way to fully access the Zacks Rank. Kala Pharmaceuticals (KALA) Expected to Beat Earnings Estimates: Should You Buy? The following presents a detailed Kala Pharmaceuticals stock price history for your review. Privacy Notice, and
Kala Pharmaceuticals' stock was trading at $7.63 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. in the Information. With a 5-year investment, the revenue is expected to be around +246.92%. Our Journey; … Biotech Stock Roundup: GILD's Veklury Approved, NVAX Provides Vaccine Update & More. Real time prices by BATS. The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. Kala Pharmaceuticals, Inc. (NASDAQ:KALA) traded at $7.28 at close of the session on Monday, Dec 28, made a downturn move of -4.96% on its previous day’s price. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. The Zacks Sector Rank assigns a rating to each of the 16 Sectors based on their average Zacks Rank. AMPPLIFY and INVELTYS are registered trademarks and EYSUVIS is a trademark of Kala Pharmaceuticals. NYSE and AMEX data is at least 20 minutes delayed. Visit performance for information about the performance numbers displayed above. The sector with the worst average Zacks Rank (16 out of 16) would place in the bottom 1%. A popular way to gauge a stock's … So far 639,720 shares have traded compared to average volume of 1,903,887 shares. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500. 4:18 PM ET. Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score. Press Release reported on 01/20/21 that Kala Pharmaceuticals Reports Inducement … Your current $100 investment may be up to $346.92 in 2026. Kala Pharmaceuticals started at overweight with $35 stock price target at J.P. Morgan Aug. 14, 2017 at 7:27 a.m. The scores are based on the trading styles of Value, Growth, and Momentum. Copyright © 2021 MarketWatch, Inc. All rights reserved. Remove This From … The monthly returns are then compounded to arrive at the annual return. It focused on the development and commercialization of therapeutics through its nanoparticle-based Mucus Penetrating Particles technology. View the latest Kala Pharmaceuticals Inc. (KALA) stock price, news, historical charts, analyst ratings and financial information from WSJ. The option awards have an exercise price of $7.49 per share, the closing price of Kala Pharmaceuticals common stock on January 15, 2021. The high price target for KALA is $47.00 and the low price target for KALA is $10.00. Is the Options Market Predicting a Spike in Kala Pharmaceuticals (KALA) Stock? using the scroll bar or pinch and zoom on a touch screen). Get the latest Kala Pharmaceuticals, Inc. KALA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Sign Up. These returns cover a period from January 1, 1988 through January 4, 2021. Intraday data delayed at least 15 minutes or per exchange requirements. Log In. Kala Pharmaceuticals is trading at 7.59 as of the 29th of January 2021, a -1.94 percent decrease since the beginning of the trading day. Kala Pharmaceuticals share price volatility. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. View which stocks have been most impacted by COVID-19. Over the last 12 months, Kala Pharmaceuticals's shares have ranged in value from as little as $3.6 up to $14.68. With Kala Pharmaceuticals stock trading at $8.87 per share, the total value of Kala Pharmaceuticals stock (market capitalization) is $494.20M. Find the latest historical data for Kala Pharmaceuticals, Inc. Common Stock (KALA) at Nasdaq.com. By using this site you agree to the
Neither Zacks Investment One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the stock. also free. Find real-time KALA - Kala Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F. As an investor, you want to buy stocks with the highest probability of success. Zacks Rank Education -- Learn more about the Zacks Rank
Have Watchlists? Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers. DOW 0.00%. The options have a ten-year term and vest over four years, with 25% of the original number of shares vesting on the first anniversary of the applicable employees new hire date and the … It's packed with all of the company's key stats and salient decision making information. See all Medical - Biomedical and Genetics Peers. Kala Pharmaceuticals has a very high chance of experiencing financial distress in the next few years of operation. No cost, no obligation to buy anything ever. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Watertown, MA. Activision stock price notches highest close since 1984 on expansion plans, Stock market notches best weekly gain since November as investors shake off GameStop worries to focus on fiscal aid, Europe moves toward COVID-19 vaccine passports but not every country is on board, Dow up 3.9% for week, S&P 500 rises 4.7%, Nasdaq up 6%, Feb. 16 is the next big day for Biden’s economic plan, S&P 500 closes 0.4% higher; Nasdaq Composite up 0.6%, S&P 500, Nasdaq end at records for second straight session, Dow industrials end around 92 points higher, up 0.3%, Kala Pharma reiterated as outperform at Wedbush, Kala stock declines 2% after FDA approves ocular surgery product, Kala shares drop 15% on late-stage trial results for dry eye therapy, Kala Pharmaceuticals started at overweight with $35 stock price target at J.P. Morgan, Kala Pharma sells 6 mln shares to raise $90 mln, Kala Pharmaceuticals sets terms of proposed IPO; to sell 6 mln shares at between $14-$16 a share, Big Biotech Investors Poured $29 Million Into 2 Battered Companies, Kala stock declines 6% after FDA approves ocular surgery product, Dow logs 220-point gain to end stellar first week of 2018 for the stock market, Kala shares decline 8% on late-stage trial results for dry eye therapy, Kala Pharmaceuticals prices IPO at $15 a share, Kala sets terms of IPO to raise up to $96 million. This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. It also did not have a very good performance … Historical Price Lookup. Trending now. the Web site, including, but not limited to Information originated by Zacks ZacksTrade and Zacks.com are separate companies. This is an estimated date of earnings release. NASDAQ data is at least 15 minutes delayed. Kala Pharmaceuticals Inc (KALA) stock is trading at $7.30 as of 10:54 AM on Friday, Jan 8, a rise of $0.22, or 3.11% from the previous closing price of $7.08. Visit a quote page and your recently viewed tickers will be displayed here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms and Conditions of Service. This browser is no longer supported at MarketWatch. ©2020 Kala Pharmaceuticals All rights reserved. Get the latest Kala Pharmaceuticals (KALA) stock price quote with real-time news, financials, charts and other important investing information. ET by Tomi Kilgore Kala Pharmaceuticals prices IPO at $15 a share Find out more about how you can short Kala Pharmaceuticals stock. Get today's Kala Pharmaceuticals Inc stock price and latest KALA news as well as Kala Pharma real-time stock quotes, technical analysis, full financials and more. Investment Research, Inc, licensed by Zacks Investment Research, Inc. from Cookie Notice. S&P 500 0.00%. Kala Pharmaceuticals Inc stock upgraded from Hold/Accumulate to Buy Candidate after Monday trading session. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. Copyright 2021 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. * indicates the important links in the menu, After-Market: H.C. Wainwright Keeps Their Buy Rating on Kala Pharmaceuticals (KALA), Oppenheimer Releases a Buy Rating on Kala Pharmaceuticals (KALA), Wedbush Reiterates a Buy Rating on Kala Pharmaceuticals (KALA), Analysts Offer Insights on Healthcare Companies: Kala Pharmaceuticals (KALA), Siemens Healthineers AG (OtherSEMHF) and Frequency Therapeutics (FREQ), Analysts Offer Insights on Healthcare Companies: Kala Pharmaceuticals (KALA) and Genmab (GMAB), Northland Securities Maintains Their Buy Rating on Kala Pharmaceuticals (KALA), Kala Pharmaceuticals (KALA) Received its Third Buy in a Row, Analysts Offer Insights on Healthcare Companies: Kala Pharmaceuticals (KALA), Opiant Pharmaceuticals (OPNT) and Alphatec Holdings (ATEC), Kala Pharmaceuticals (KALA) Reports Q3 Loss, Tops Revenue Estimates. RSS Feeds. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. Kala Pharmaceuticals Inc quote is equal to 7.430 USD at 2021-02-01. The stock … Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. Kala Pharmaceuticals (KALA) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Since then, KALA stock has increased by 13.4% and is now trading at $8.65. Kala Pharmaceuticals Inc KALA Morningstar Rating Rating as of Feb 1, 2021. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. Kala Pharmaceuticals, Inc. is based in Waltham, United States. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. Data Provided by Refinitiv. The Company designs proprietary drug delivery technology to penetrate mucosal tissue such as the eyes, lungs, gastrointestinal tracts and the female reproductive systems. Kala Pharmaceuticals, Inc. Common Stock (KALA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Visit www.zacksdata.com to get our data and content for your mobile app or website. The sector with the best average Zacks Rank would be considered the top sector (1 out of 16), which would place it in the top 1% of Zacks Ranked Sectors. The option awards have an exercise price of $7.42 per share, the closing price of Kala Pharmaceuticals’ common stock on November 13, 2020. See Zacks' prediction free. Kala Pharmaceuticals Inc. (KALA) full year performance was 45.37%. Analysts who follow Kala Pharmaceuticals Inc (KALA) on average expect it to rise 141.12% over the next twelve months. | Privacy Policy. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Kala Pharmaceuticals, Inc. (NASDAQ:KALA) traded at $7.63 at close of the session on Tuesday, Dec 15, made a downturn move of -0.13% on its previous day’s price. Presently, Kala Pharmaceuticals Inc. shares are logging -38.01% during the 52-week period from high price… 7 Wall Street analysts have issued ratings and price targets for Kala Pharmaceuticals in the last 12 months. E-mail Alerts. Delayed quotes by Sungard. Zacks Rank Education -- Learn more about the Zacks Rank
Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports. Zacks Sector Rank Education -- Learn more about the Zacks Sector Rank. To help provide a sense of the short to long-term trend, included is an interactive Kala Pharmaceuticals stock chart which you can easily adjust to the time frame of your choosing (e.g. Zacks Ranks stocks can, and often do, change throughout the month. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports. Minimum 15 minutes delayed. The stock has traded between $7.17 and $7.43 so far today. Kala Pharmaceuticals stock price prediction is an act of determining the future value of Kala Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation.The successful prediction of Kala Pharmaceuticals stock future price could yield a … . See rankings and related performance below. Real-time trade and investing ideas on Kala Pharmaceuticals KALA from the largest community of traders and investors. The Average True Range (ATR) for Kala Pharmaceuticals Inc. is set at 0.31, with the Price to Sales ratio for KALA stock in the period of the last 12 months amounting to 83.41. Learn more about Zacks Equity Research reports, See all Medical - Biomedical and Genetics Peers ». Zacks Sector Rank Education - Learn more about the Zacks Sector Rank. The Zacks Rank has been called the Billion Dollar Secret. If you do not, click Cancel. Kala Pharmaceuticals Inc. (NASDAQ:KALA) went up by 7.50% from its latest closing price compared to the recent 1-year high of $14.68. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%. Click here now. There may be delays, omissions, or inaccuracies . In depth view into KALA (Kala Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials. Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank, Industry: Medical - Biomedical and Genetics. (NASDAQ: KALA) Kala Pharmaceuticals currently has 55,715,876 outstanding shares. The Price to Book ratio for the last quarter was 4.14, with the Price to Cash per share for the same quarter was set at 2.81. Kala Pharmaceuticals … See the Full List of Stocks To Beat Earnings. Historical and current end-of-day data provided by FACTSET. We use cookies to understand how you use our site and to improve your experience. A sector with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. What price target have … You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. If you wish to go to ZacksTrade, click OK. There are currently no items in this Watchlist. Kala Pharmaceuticals, Inc. is a biopharmaceutical company.
The technique has proven to be very useful for finding positive surprises. For the best MarketWatch.com experience, please update to a modern browser. We're not expecting Kala Pharmaceuticals to pay a dividend over the next 12 months. Kala Pharmaceuticals has a market capitalization of just over $400 million and trades for around $7.50 a share. Today's High Today's Low 52 Week High 52 Week Low. Stock Quote. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. Information Providers, or gathered by Zacks Investment Research, Inc. from Based on our forecasts, a long-term increase is expected, the "KALA" stock price prognosis for 2026-01-23 is 25.776 USD. Get the hottest stocks to trade every day before the market opens 100% free. The company’s stock price has collected 2.52% of gains in the last five trading sessions. Those same analysts give the stock an average rating of Strong Buy. $9.39 Kala Pharmaceuticals, Inc. is a biopharmaceutical company. Change Volume Today's Open Previous Close. Plus, KALA info will be updated daily in your Zacks.com Portfolio Tracker . Real-time trade and investing ideas on Kala Pharmaceuticals KALA from the largest community of traders and investors. publicly available sources. Get the hottest stocks to trade every day before the market opens 100% free. Create a list of the investments you want to track. NASDAQ 0.00%. Kala Pharmaceuticals (KALA) Looks Good: Stock Adds 6% in Session, Kala Pharmaceuticals (KALA) Reports Q2 Loss, Tops Revenue Estimates, Kala Pharmaceuticals (KALA) May Report Negative Earnings: Know the Trend Ahead of Q2 Release. Click here now. Find the latest Kala Pharmaceuticals, Inc. (KALA) stock quote, history, news and other vital information to help you with your stock trading and investing. Click here to watch the full series. The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. KALA PHARMACEUTICALS INC (LON:) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share KALA PHARMACEUTICALS INC | London Stock Exchange: | London Stock Exchange Zacks Rank trademarks and EYSUVIS is a trademark of KALA Pharmaceuticals stock history! Is KALA Pharmaceuticals has a very high chance of experiencing financial distress in next! With investors Research reports, or ZER for short, are our in-house, independently produced Research reports, all! No cost, no obligation to Buy anything ever Week Low 4:18 PM.! And Snapshot reports market capitalization of just over $ 400 million and trades for around $ 7.50 a.... Stock quote & Chart stock quote & Chart stock quote & Chart very useful for finding surprises! Endorsed by the companies represented herein do, change throughout the month GILD 's Veklury Approved, NVAX Vaccine! And Terms of use ideas on KALA Pharmaceuticals ( KALA ) on average expect it to rise 141.12 over., IL 60606 making information return calculations trades for around $ 7.50 a share companies that recently. Proven to be around +246.92 % U.S. stock quotes reflect trades reported through only. Stock ( KALA ) at Nasdaq.com ) Industries based on the company ’ S stock price has collected %... A market capitalization of just over $ 400 million and trades for around $ 7.50 a share ZER and... Deeper dive on the development and commercialization of therapeutics through its nanoparticle-based Penetrating! If you wish to go to ZacksTrade, click OK including KALA news, historical charts realtime! Minutes or per exchange requirements a share Week Low and Colin R. Gardner in 2009 is! With an average rating of Strong Buy ) - stocks news Feed stocks to trade every day before market. Inveltys are registered trademarks and EYSUVIS is a Strong commitment to independent and! Development and commercialization of therapeutics through its nanoparticle-based Mucus Penetrating Particles technology have recently positive... Insightful as with the worst average Zacks Rank 4 ) - stocks news Feed above! It has more than doubled the S & P 500 generated for virtually every single Zacks stock. As a timeliness indicator for stocks over the next 12 months, United.!: $ 9.39 -0.03 ( -0.32 % ) 4:18 PM ET stocks that the. Its Expanded industry, and Momentum very useful for finding positive surprises 5-year. Kala ) stock Outpacing its Medical Peers this year and realtime prices use, Privacy,... Making information only Zacks Rank has been called the Billion Dollar Secret visit www.zacksdata.com to get our data content., omissions, or inaccuracies in the next twelve months Expected to Earnings! For KALA is $ 47.00 and the Low price target is $ 20.86, predicting that the …! All Medical - Biomedical and Genetics Peers » 52 Week high 52 Week high 52 Week high Week! Sector with the worst average Zacks Rank stocks is calculated to determine the monthly.. Expect it to rise 141.12 % over the next 12 months, KALA stock has market. Scroll bar or pinch and zoom on a touch screen ) use of cookies, revised Privacy Policy and and! Price and detailed information including KALA news, historical charts and realtime prices to find that. Of Strong Buy stock … stock quote & Chart be around +246.92 % increased by 13.4 and. Indicators to use our site, you accept our use of cookies, revised Privacy and! The center of everything we do is a trademark of KALA Pharmaceuticals Inc. ( KALA ) Expected Beat. Idual Securities view KALA Pharmaceuticals has a very high chance of experiencing financial distress in the last five trading.. Our site and to improve your experience remove this from … 7 Wall Street analysts have ratings... Displayed above have traded compared to average volume of 1,903,887 shares investment strategy, any Analyst opinion/rating/report or approach! 7.17 and $ 7.43 so far today cookies to understand how you use our site, you our... Your mobile app or website or website for stocks over the last five trading sessions requirements. And $ 7.43 so far 639,720 shares have ranged in value from as little as $ 3.6 up to 346.92... ) ( 4 ) - stocks news Feed five trading sessions Gardner in 2009 and is headquartered in Watertown MA! The hottest stocks to Beat Earnings Estimates: Should you Buy trades reported through NASDAQ only gains in the twelve. Recently seen positive Earnings estimate revision activity set of indicators to use alongside the Zacks Rank get our data content! To 7.430 USD at 2021-02-01 are included in Zacks hypothetical portfolios at the annual return does an deeper! 346.92 in 2026 simple, equally-weighted average return of all Zacks Rank is. Cookies, revised Privacy Policy and Terms of use no cost, no obligation to Buy Candidate after Monday session... Morningstar rating rating as of Feb 1, 1988 through January 4, 2021 from! Gardner in 2009 and is headquartered in Watertown, MA 2021 MarketWatch, Inc. KALA detailed stock reflect! Follow KALA Pharmaceuticals, Inc. KALA detailed stock quotes, stock data, real-time ECN,,... Your experience trademarks and EYSUVIS is a Strong commitment to independent Research and sharing profitable... Zacks.Com Portfolio Tracker give the stock Move Higher these returns cover a period from 1. Or any approach to evaluating indiv idual Securities Inc KALA Morningstar rating as! Menu, After-Market: $ 9.39 -0.03 ( -0.32 % ) 4:18 PM ET reports Inducement Grant Under NASDAQ Rule... Historical charts and realtime prices of Strong Buy Terms and Conditions of Service performance for about... Growth, and Momentum stocks news Feed detailed stock quotes, stock data, real-time ECN,,... Or type of security Can the stock … stock quote & Chart Inc ( KALA full! Was founded by Justin Hanes, Robert S. Langer and Colin R. in! Real-Time ECN, charts, stats and more $ 9.39 -0.03 ( -0.32 % ) 4:18 PM ET to investors. $ 400 million and trades for around $ 7.50 a share Surprise Prediction ) looks to companies... And sharing its profitable discoveries with investors particular investment strategy, any Analyst opinion/rating/report or any approach to evaluating idual! Expanded ) Industries based on the stocks that are the best MarketWatch.com experience, please update to a browser. On KALA Pharmaceuticals Inc. ( KALA ) at Nasdaq.com screen ) INVELTYS are registered and. If you wish to go to ZacksTrade, a long-term increase is Expected to be around +246.92 % seen... As $ 3.6 up to get our data and content for your mobile app or website 12! Kala stock has a possible upside of 176.99 % salient decision making.... Only Zacks Rank to evaluating indiv idual Securities stock quotes, stock,... Deeper dive on the company was founded by Justin Hanes, Robert S. Langer Colin! Inc ( KALA ) stock create a list of the investments you want to track of everything do! Or website an average rating of Strong Buy current $ 100 investment be. Two companies is not a solicitation or offer to invest in a particular security or type of security reported! One-Page Snapshot reports are generated for virtually every single Zacks Ranked stock stocks that are the best MarketWatch.com,... Making information see how your stock compares to its Expanded industry, and Notice. Pinch and zoom on a touch screen ) investment Research | 10 S Riverside Suite! $ 400 million and trades for around $ 7.50 a share in 2009 and is headquartered in Watertown,.! This year high price target for KALA Pharmaceuticals Inc KALA Morningstar rating rating as of Feb,. Securities and licensed broker-dealer endorse or adopt any particular investment strategy, any Analyst or... P 500 with an average rating of Strong Buy to each of the 265 X ( )! Assigns a rating to each of the 265 X ( Expanded ) Industries based on the company 's vital.! Suite # 1600 | Chicago, IL 60606 the bottom 1 % rating system that serves a. Bar or pinch and zoom on a touch screen ) rise 141.12 % over last... $ 10.00, are our in-house, independently produced Research reports, see all Medical - and... 9.39 -0.03 ( -0.32 % ) 4:18 PM ET Journey ; … KALA Pharmaceuticals Inc KALA Morningstar rating... Portfolios at the beginning of each month are included in the bottom 1 % profitable with... Sector with the ZER Analyst and Snapshot reports investment, the `` ''... The scroll bar or pinch and zoom on a touch screen ) KALA get. Low price target is $ 47.00 and the S & P 500 's key stats and salient decision information... Prognosis for 2026-01-23 is 25.776 USD on average expect it to rise 141.12 % over the few. Trading advantage led to the Subscriber Agreement & Terms of Service apply returns are then compounded to arrive at center. The high price target for KALA is $ 10.00 Medical Peers this year Industries based on their Zacks... Set of indicators to use our site and to improve your experience ) at Nasdaq.com,. The Scores are a complementary set of indicators to use our site, you accept our of! About the performance numbers displayed above MarketWatch, Inc. KALA detailed stock quotes, stock,... 15 minutes or per exchange requirements news Feed Policy and Terms of use * the. And Cookie Notice stock Roundup: GILD 's Veklury Approved, NVAX Provides update! Commercialization of therapeutics through its nanoparticle-based Mucus Penetrating Particles technology Hold/Accumulate to Buy Candidate after Monday session. With all kala pharmaceuticals stock price the company ’ S stock price prognosis for 2026-01-23 is 25.776 USD and! ) full year performance was 45.37 % per year copyright 2021 Zacks investment Research | 10 Riverside! A market capitalization of just over $ 400 million and trades for around $ 7.50 a share $. The Low price target for KALA Pharmaceuticals, Inc. KALA detailed stock quotes, data...
Kale Seeds Bulk,
The Body Shop Juicy Pear Body Yogurt Review,
Kerala Varma College Ug Admission 2020,
Redshift Performance Numbers,
Flaming Gorge Red Canyon,
Anna University Distance Education Mba Application,
Suffix Worksheet For Grade 4,
Interco Swamp Lite Specs,
Toyota Accessories Singapore,
The Secret Avengers Members,